Search

Jennifer Leigh-stewar Ghand

Examiner (ID: 2000, Phone: (571)270-5844 , Office: P/3766 )

Most Active Art Unit
3766
Art Unit(s)
3766, 3796, 3762, 3792
Total Applications
772
Issued Applications
416
Pending Applications
96
Abandoned Applications
272

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 749226 [patent_doc_number] => 07022472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Mutations in human MLH1 and human MSH2 genes useful in diagnosing colorectal cancer' [patent_app_type] => utility [patent_app_number] => 09/426548 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5470 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022472.pdf [firstpage_image] =>[orig_patent_app_number] => 09426548 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/426548
Mutations in human MLH1 and human MSH2 genes useful in diagnosing colorectal cancer Oct 21, 1999 Issued
Array ( [id] => 1272206 [patent_doc_number] => 06649158 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Methods and compositions to induce antitumor response' [patent_app_type] => B1 [patent_app_number] => 09/416813 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9214 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649158.pdf [firstpage_image] =>[orig_patent_app_number] => 09416813 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/416813
Methods and compositions to induce antitumor response Oct 12, 1999 Issued
Array ( [id] => 4295372 [patent_doc_number] => 06197756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Gene transfer of E2F-1 to inhibit vascular smooth muscle cell accumulation in vascular tissue' [patent_app_type] => 1 [patent_app_number] => 9/416929 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 7105 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197756.pdf [firstpage_image] =>[orig_patent_app_number] => 416929 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/416929
Gene transfer of E2F-1 to inhibit vascular smooth muscle cell accumulation in vascular tissue Oct 12, 1999 Issued
Array ( [id] => 1449687 [patent_doc_number] => 06455284 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicals' [patent_app_type] => B1 [patent_app_number] => 09/417557 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14420 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455284.pdf [firstpage_image] =>[orig_patent_app_number] => 09417557 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/417557
Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicals Oct 12, 1999 Issued
Array ( [id] => 1532110 [patent_doc_number] => 06410314 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Episomally replicating vector, its preparation and use' [patent_app_type] => B1 [patent_app_number] => 09/412825 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6624 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410314.pdf [firstpage_image] =>[orig_patent_app_number] => 09412825 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/412825
Episomally replicating vector, its preparation and use Oct 4, 1999 Issued
Array ( [id] => 4323592 [patent_doc_number] => 06329171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => '23484, A novel human ubiquitin protease' [patent_app_type] => 1 [patent_app_number] => 9/408865 [patent_app_country] => US [patent_app_date] => 1999-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36627 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329171.pdf [firstpage_image] =>[orig_patent_app_number] => 408865 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/408865
23484, A novel human ubiquitin protease Sep 29, 1999 Issued
Array ( [id] => 1479536 [patent_doc_number] => 06451994 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => '23413, a novel human ubiquitin protease' [patent_app_type] => B1 [patent_app_number] => 09/406045 [patent_app_country] => US [patent_app_date] => 1999-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33417 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451994.pdf [firstpage_image] =>[orig_patent_app_number] => 09406045 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/406045
23413, a novel human ubiquitin protease Sep 26, 1999 Issued
09/404895 PLURIPOTENT EMBRYONIC-LIKE STEM CELLS, COMPOSITIONS METHODS AND USES THEREOF Sep 23, 1999 Abandoned
Array ( [id] => 4255507 [patent_doc_number] => 06207877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding' [patent_app_type] => 1 [patent_app_number] => 9/404208 [patent_app_country] => US [patent_app_date] => 1999-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1934 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207877.pdf [firstpage_image] =>[orig_patent_app_number] => 404208 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/404208
Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding Sep 22, 1999 Issued
09/406257 MATERIALS AND METHODS FOR INDUCING ANGIOGENESIS AND THE REPAIR OF MAMMALIAN TISSUE Sep 22, 1999 Abandoned
09/400967 NUCLEIC ACIDS ENCODING VITAMIN D RESPONSE ELEMENT BINDING PROTEINS, PRODUCTS RELATED THERETO, AND METHODS OF USING SAME Sep 21, 1999 Abandoned
09/380377 PROCOLLAGEN ASSEMBLY Sep 15, 1999 Abandoned
Array ( [id] => 6999881 [patent_doc_number] => 20010053352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'ADENOVIRUS VECTORS CONTAINING CELL STATUS-SPECIFIC RESPONSE ELEMENTS AND METHODS OF USE THEREOF' [patent_app_type] => new [patent_app_number] => 09/392822 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16348 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053352.pdf [firstpage_image] =>[orig_patent_app_number] => 09392822 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/392822
Adenovirus vectors containing cell status-specific response elements and methods of use thereof Sep 8, 1999 Issued
Array ( [id] => 1248003 [patent_doc_number] => 06673569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'DsbA/DsbB/DsbC/DsbD expression plasmid' [patent_app_type] => B1 [patent_app_number] => 09/393171 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11004 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673569.pdf [firstpage_image] =>[orig_patent_app_number] => 09393171 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/393171
DsbA/DsbB/DsbC/DsbD expression plasmid Sep 8, 1999 Issued
Array ( [id] => 1231680 [patent_doc_number] => 06693087 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Nucleic acid molecules encoding POMP91A protein of Chlamydia' [patent_app_type] => B1 [patent_app_number] => 09/377850 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 16880 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693087.pdf [firstpage_image] =>[orig_patent_app_number] => 09377850 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/377850
Nucleic acid molecules encoding POMP91A protein of Chlamydia Aug 19, 1999 Issued
08/973589 ESSENTIAL OLIGONUCLEOTIDES OF VERTEBRATE TELOMERASE Aug 19, 1999 Abandoned
Array ( [id] => 6611605 [patent_doc_number] => 20020064520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'TARGETED ARTIFICIAL GENE DELIVERY' [patent_app_type] => new [patent_app_number] => 09/377153 [patent_app_country] => US [patent_app_date] => 1999-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8831 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064520.pdf [firstpage_image] =>[orig_patent_app_number] => 09377153 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/377153
TARGETED ARTIFICIAL GENE DELIVERY Aug 18, 1999 Abandoned
09/376184 ENCAPSIDATED RECOMBINANT POLIOVIRUS NUCLELIC ACID AND METHODS OF MAKING AND USING SAME Aug 16, 1999 Abandoned
Array ( [id] => 5921880 [patent_doc_number] => 20020115202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'ADENOVIRAL VECTORS INCLUDING DNA SEQUENCES ENCODING ANGIOGENIC INHIBITORS' [patent_app_type] => new [patent_app_number] => 09/373938 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11382 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115202.pdf [firstpage_image] =>[orig_patent_app_number] => 09373938 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/373938
ADENOVIRAL VECTORS INCLUDING DNA SEQUENCES ENCODING ANGIOGENIC INHIBITORS Aug 12, 1999 Abandoned
09/367170 EXPRESSION OF PROTEINS FOR TREATING ASTHMA VIA LIGAND MEDIATED ACTIVATION OF THEIR ENCODING GENES Aug 8, 1999 Abandoned
Menu